The generic release date for Cymbalta (duloxetine) has already occurred. The U.S. Food and Drug Administration (FDA) approved the first generic versions of Cymbalta in November 2010 [1].
When did Cymbalta patents expire?
Cymbalta's primary patent protection in the United States expired in June 2013 [2]. However, a secondary patent related to its use in treating generalized anxiety disorder was set to expire later. The drug's exclusivity period ended when generic manufacturers were able to launch their versions [1][3].
Who makes generic Cymbalta?
Multiple pharmaceutical companies manufacture generic versions of duloxetine, including Aurobindo Pharma, Cipla, Dr. Reddy's Laboratories, Mylan (now Viatris), and Teva Pharmaceuticals [4][5].
How much does generic Cymbalta cost?
The cost of generic duloxetine is significantly lower than the brand-name Cymbalta. Prices can vary depending on the dosage, quantity, and pharmacy, but generally, a 30-day supply can range from approximately $10 to $30 [6].
What conditions does duloxetine treat?
Duloxetine is prescribed to treat major depressive disorder, generalized anxiety disorder, fibromyalgia, and neuropathic pain associated with diabetic peripheral neuropathy [3][7]. It is also used for chronic musculoskeletal pain [3].